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Abstract: Covid-19 virus still attacks various worldwide sectors, especially health. The 
current problem is that the Covid-19 vaccine is still in progress, so the best strategy to 
deal with this problem is to prevent this disease's spread. In the laboratory sector, 
complete blood cells tend to use as a screening method for disease, especially 
infectious disease. This study describes the CBCs findings among Covid-19 patients 
at Covid-19 reference hospitals in West Nusa Tenggara. This study will enhance the 
data to provide early diagnosis for patients with Covid-19. This was a retrospective 
study conducted from Mei to July 2020. A total of four hospitals have access to 85 
medical records of Covid-19 patients. The patient’s data included in this study should 
have (1) initials; (2) Gender; (3) Age; (4) Patients' disease other than Covid-19; and 
(5) The results of the first CBCs examination. Incomplete data excluded from the 
study. The CBCs data collected from Hospital Management Information Systems 
(HMIS) and Laboratory Information Systems (LIS). The data were analyzed 
descriptively. The results showed that 5.88% of patients with comorbidities or another 
disease reported abnormal CBCs results. In comparison, another 94.12% of patients 
without another disease than Covid-19 tend to present normal results. In conclusion, 
most of the CBC's findings among Covid-19 patients in West Nusa Tenggara show 
normal value among patients with no disease other than Covid-19. 
Keyword: Covid-19; complete blood cells; hospital management information systems; 
laboratory information systems 
INTRODUCTION 
In recorded human history, the latest Covid-19 is the third coronaviral (CoV) 
outbreak (Yi et al., 2020). The world has faced highly pathogenic human CoVs, i.e., 
Severe Acute Respiratory Syndrome (SARS-CoV) and Middle East Respiratory 
Syndrome (MERS-CoV), which initially triggered an outbreak in China and Saudi 
Arabia in 2003 and 2012, respectively. The virus spread and reaches quickly 
worldwide, with horrible morbidity and mortality (Paules et al., 2020). The Covid-19 
infection symptoms begin to appear after a five to six-day incubation period (Qun Li et 
al., 2020). The time between the onset of COVID-19 symptoms to death ranges from 
6-41 days, with a median of 14 days (Wang et al., 2020). 
As the symptoms, fever is often occurring among Covid-19 cases, which can 
be accompanied by no symptom.  Dry cough, shortness of breath, dizziness, muscle 
ache, sore throat, rhinorrhea, headache, diarrhea, chest pain, vomiting, and nausea 
are other symptoms of Covid-19 infection. Sometimes, patients had no fever, and 
several had no irregular radiological findings (Guan et al., 2020). 
A covid-19 pandemic occurs to be an issue to the world. All health professionals 
have attempted to find out how to prevent, manage, and cure this pandemic. Covid-
Medical Laboratory Technology Journal  
   
 Available online at : http://ejurnal-analiskesehatan.web.id 
ISSN 2461-0879 
 




6 (2), 2020, 152-162 
P a g e  | 153 
 
Copyright © 2020, MLTJ, ISSN 2461-0879 
 
19 patients with and without symptoms or abnormalities should be screened for the 
virus for early diagnosis (Chen et al., 2020). Besides, many studies have reported 
improvements in the laboratory detection data of Covid-19 patients, and studies have 
usually concentrated on one or more hematology parameters (Fan et al., 2020; Y. 
Huang et al., 2020; Terpos et al., 2020).  
Infected patients with COVID-19, whether hospitalized or outpatient, are at high 
risk for venous thromboembolism (Terpos et al., 2020). Thrombocytosis, lymphopenia, 
and increased C-reactive protein were typical laboratory findings, although the majority 
of Covid-19 patients (Huang et al., 2020). Another study from Fan (2020) reported that 
older age, lymphopenia, and raised lactate dehydrogenase (LDH) were associated 
with intensive care unit admissions. Patients who transferred to the intensive care unit 
had a deeper nadir absolute lymphocyte count (ALC), absolute monocyte count 
(AMC), hemoglobin, and a higher peak of absolute neutrophil count (ANC) and LDH 
than patients who did not need ICU stay. 
The most widely conducted hematological laboratory test worldwide is a CBC, 
and most routine laboratories fitted with a hematology analyzer. Some of the studies 
reported a variety of abnormal changes in CBCs parameters among Covid-19 patients. 
There is a lack of a summary of the data and the geographical variety, so it is essential 
to conduct this study to describe the CDCs findings among Covid-19 patients at Covid-
19 reference hospitals in West Nusa Tenggara, Indonesia.  
 
MATERIALS AND METHOD 
This research was conducted in May-July 2020 at the Mataram City Hospital, 
Bhayangkara Hospital, Patuh Patut Patju Hospital, and North Lombok Regional 
Hospital.  This study's ethical feasibility comes from the Ethics Committee of the 
Faculty of Medicine, Al-Azhar Islamic University, with number: 19/EC/FK-06/UNIZAR/ 
V/2020. The 85 patients’ data used in this study was the first result of patients' CBCs 
since confirmed positive for Covid-19. The data included in this study should have (1) 
initials; (2) Gender; (3) Age; (4) Patients’ disease other than Covid-19; and (5) The 
results of the first CBCs examination. Incomplete data excluded from the study. The 
variables studied were gender, age, hemoglobin, hematocrit, number of leukocytes, 
number of platelet cells, number of erythrocyte cells, erythrocyte index (MCV, MCH, 
MCHC), leukocyte count (absolute and percentage), red cell distribution width (RDW-
CV), and neutrophils-lymphocytes ratio. 
Data collection started from the Hospital Management Information Systems 
(HIMS) to see the medical record number, initial, gender, age, and comorbidities of 
Covid-19 patients. Some hospitals had HIMS that integrated with the Laboratory 
Information System (LIS) so that patient data and CBCs results can be accessed more 
easily. In another hospital, researchers must continue with patient data from HIMS to 
obtain CBCs of patients in the laboratory if HIMS and LIS are not integrated. The data 
obtained grouping by age to the study variables, computerized, and then presented in 
tabular form. 
  
RESULTS AND DISCUSSION 
 This study conducted using 85 data from the medical record. The data 
calculated, and the result shows that female patients (64%) with positive Covid-19 
status were more than male patients (36%) (Figure 1).  
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Figure 1. Gender distribution of Covid-19 patient’s data (n=85) 
 
Figure 2 shows that patients with positive Covid-19 were one patient aged two 
years old (<5 years old), eight patients aged 6-19 years old, 14 patients aged 20-29 
years old, 17 patients aged 30-39 years old, 18 patients aged 40-49 years old, 14 
patients aged 50-59 years old, and 13 patients aged more than 60 years old.  
Figure 2. Age Distribution of Covid-19 Patient’s Data (n=85) 
 
Table 1. Data Characteristics among Covid-19 Patients without Comorbidity Disease 
 
Variable   n=80 
n % Mean SD Min Max 
Sex 
      
Male 49 61.25 
    
Female 31 38.75 
    
Age 
  
39.84 16.34 2.00 75.00 
<5 1 1.25 
    
6-19 8 10 
    
20-29 14 17.5 
    
30-39 17 21.25 
    
40-49 18 22.5 
    
50-59 13 16.25 
    
>60 9 11.25 
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Table 2. Hemoglobin, Red Blood Cell, Hematocrit, Platelet, White Blood Cell, MCV, 
MCH, and MCHC Results among Covid-19 Patients without Comorbidity Disease 
 
Variable   n=80 
n % Mean SD Min Max 
Hemoglobin (13 - 18 mmol/L)  
 
13.65 2.57 6.20 24.30 
Low 18 22.5 
    
Normal 58 72.5 
    
High 4 5 
    
RBC (4.4 – 5.6 x 1012 
cell/L) 
  
4.83 0.75 2.10 6.56 
Low 13 16.25 
    
Normal 54 67.5 
    
High 13 16.25 
    
Hematocrit (40% - 50%) 
 
39.77 6.52 16.60 52.20 
Low 21 26.25 
    
Normal 55 68.75 
    
High 4 5 
    
Platelets (170 – 380 x109/L) 286.99 90.41 21.00 620.00 
Low 5 6.25 
    
Normal 64 80 
    
High 11 13.75 
    
MCV (80 – 100 fL) 
  
80.61 12.04 7.90 94.20 
Low 26 32.5 
    
Normal 54 67.5 
    
MCH (28– 34 pg) 
  
28.19 3.74 17.30 50.50 
Low 35 43.75 
    
Normal 44 55 
    
High 1 1.25 
    
MCHC (32 – 36 g/dL) 
 
33.89 1.68 26.40 37.40 
Low 5 6.25 
    
Normal 68 85 
    
High 7 8.75 
    
WBC (3.20 – 10 x109/L) 9.25 4.72 3.69 36.13 
Low 1 1.25 
    
Normal 53 66.25 
    
High 26 32.5 
    
 
The results from 80 positive Covid-19 patients show mostly normal conditions 
on all parameters from the first CBC examination (at first admission) (Table 1). The 
standard value of assessing the low, high, and normal value of each parameter is 
based on clinical data interpretation guidelines by the Indonesian Ministry of Health 
(2011).   
Fan et al. (2020) reported that most Singapore patients had normal CBC 
(normal Hb, WBC, and platelet count). There were no patients with moderate to severe 
thrombocytopenia, commonly seen in other viral diseases, such as dengue fever, 
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Table 3. Differential blood count, Neutrophil Lymphocyte Ratio, and Platelet 
Lymphocyte Ratio results among Covid-19 Patients without Comorbidity Disease 
 
Variable   n=80 
n % Mean SD Min Max 
Basophil (0-2%) 
  
0.69 2.08 0.00 17.80 
Normal 77 96.25 
    
High 3 3.75 
    
Eosinophil (0-6%) 
  
3.37 3.13 0.00 13.40 
Normal 65 81.25 
    
High 15 18.75 




56.02 18.47 0.30 94.70 
Low 7 8.75 
    
Normal 61 76.25 
    
High 12 15 
    
Lymphocyte (15-45%) 
 
31.55 12.38 2.00 62.80 
Low 11 13.75 
    
Normal 50 62.5 
    
High 19 23.75 
    
Monocyte (0-10%) 
  
8.03 6.15 1.30 36.90 
Normal 63 78.75 
    
High 17 21.25 
    
Basophil (0-0.15 x106/L) 0.14 0.22 0.00 1.08 
Normal 60 75 
    
High 20 25 
    
Eosinophil (0-0.5 x 106/L) 0.62 1.77 0.00 14.00 
Normal 62 77.5 
    
High 18 22.5 
    
Neutrophil (1.26-7.3 x 106/L) 5.44 4.72 0.02 33.20 
Low 4 5 
    
Normal 64 80 
    
High 12 15 
    
Lymphocyte (0.8-4 x 106/L) 2.61 1.13 0.34 6.76 
Low 4 5 
    
Normal 68 85 
    
High 8 10 
    
Monocyte (0.1-0.8 x 106/L) 0.69 0.55 0.15 3.13 
Normal 63 78.75 
    
High 17 21.25 
    
NLR (3.13-5.0) 
  
2.96 5.78 0.00 36.20 
Normal 69 86.25 
    
High 11 13.75 
    
PLR (>180) 
  
140.12 111.23 10.40 720.59 
Normal 69 86.25 
    
High 11 13.75 
    
 
Normal or low hemoglobin levels cannot be used as a diagnostic parameter for 
Covid-19 infection but can be used as a supporting parameter in determining the 
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severity or recovery of patients during treatment (Fan et al., 2020; Huang et al., 2020; 
Lippi & Plebani, 2020). 
In general, the white blood cell count appears normal or decreased in Covid-19 
patients at first admission (Huang et al., 2020). The same findings were observed in 
asymptomatic patients (Hu et al., 2020). Also, age dependence has been reported to 
be associated with disease severity, and a higher WBC count has been observed in 
elderly patients than younger adults with Covid-19 (Lin et al., 2020).  
The 80 samples showed a tendency for the patient's platelet count to be normal 
because most patients did not have comorbidities, so that the severity of this disease 
was thought to be low. Huang et al. (2020) reported that as many as 8% of patients 
requiring Intensive Care Unit (ICU) care had a low platelet count compared to 4% of 
patients who did not require ICU care.  
 
Table 4. Data Characteristics among Covid-19 Patients with Another Disease 
 
Variable   n=5 
n % Mean SD Min Max 
Sex 
      
Male 5 100.00 
    
Age 
      
50-59 1 20.00 
    
>60 4 80.00 
    
Comorbid Disease 
      
Dyspnea 1 20.00 
    








    
Chronic kidney disease + 
Hypertension Stage 2 
1 20.00 
    
Pulmonary tuberculosis + 
chronic kidney disease 
1 20.00 
    
 
Table 2 shows a total of five positive Covid-19 patients with another disease 
reported. Most of them were elderly people. There were only three patients with 
comorbid disease of Covid-19 (i.e., chronic kidney disease + hypertension stage 2; 
chronic obstructive pulmonary disease; and pulmonary tuberculosis + chronic kidney 
disease). CBC parameters in this data were most abnormal in the neutrophil 
percentage, neutrophil absolute, neutrophil-lymphocyte ratio (NLR), and platelet 
lymphocyte ratio (PLR). 
Hu et al. (2020) reported that there was variability within the severe group, with 
87.5% of critically ill patients having neutrophilia. Other investigators have also 
reported neutrophilia in some elderly patients after admission (Lin et al., 2020). The 
likelihood of neutrophilia being a predictor of disease severity has been further 
supported by other investigators who investigated 82 deaths in Covid-19 patients and 
demonstrated that neutrophilia was present in 74.3% of cases after admission and 
increased to 100% in the last 24 hours before death (Zheng et al., 2020) 
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Table 5. Hemoglobin, Red Blood Cell, Hematocrit, Platelet, White Blood Cell, MCV, 
MCH, and MCHC Results among Covid-19 Patients with Another Disease 
 
Variable   n=5 
n % Mean SD Min Max 
Hemoglobin (13 – 18 
mmol/L)  
  
12.78 2.79 8 15.2 
Low 1 20.00 
    
Normal 4 80.00 
    
RBC (4.4 – 5.6 x 1012 cell/L) 
  
4.36 0.86 2.9 5.2 
Low 1 20.00 
    
Normal 4 80.00 
    
Hematocrit (40% - 50%) 
  
37.28 8.79 24 47.9 
Low 3 60.00 
    
Normal 2 40.00 
    
Platelets (170 – 380 x109/L) 
  
280 184 121 589 
Low 1 20.00 
    
Normal 3 60.00 
    
High 1 20.00 
    
MCV (80 – 100 fL) 
  
85.56 6.64 76.5 92.6 
Low 1 20.00 
    
Normal 4 80.00 
    
MCH (28– 34 pg) 
  
29.38 1.38 27.9 31.1 
Low 1 20.00 
    
Normal 4 80.00 
    
MCHC (32 – 36 g/dL) 
  
34.44 2.01 31.8 36.5 
Low 1 20.00 
    
Normal 2 40.00 
    
High 2 40.00 
    
WBC (3.20 – 10 x109/L) 
  
12.06 4.56 5.4 16.5 
Normal 2 40.00 
    
High 3 60.00 
    
 
A study in Wuhan with a sample of 40 people consisting of 15 men (37.5%) and 
25 women (62.5%) stated that absolute neutrophil levels were significantly higher in 
severe cases of Covid-19 than in severe cases (Liu et al., 2020).  
Increased NLR and age were significantly associated with disease severity. The 
binary logistic analysis identified increased NLR as an independent factor for poor 
clinical outcome of Covid-19 (Yang et al., 2020). Increased NLR is a risk factor for 
death not only in infectious diseases but also in malignancies, acute coronary 
syndromes, intracerebral hemorrhage, polymyositis, and dermatomyositis (Azab et al., 
2010; Giede-Jeppe et al., 2017; Guthrie et al., 2013; Ha et al., 2018).  
Qu et al. (2020) proposed PLR as an indicator reflecting the severity of 
inflammation in the treatment process by comparing the PLR changes during 
treatment. It was found that the higher the PLR cut-off point, the longer patient stays 
in the hospital. Therefore, the investigators speculate that changes in the 
platelet/lymphocyte ratio in the blood during treatment may reflect disease progression 
and Covid-19 patients' prognosis. This disparity in numbers may, in part, represent the 
extent of the epidemiological data available.  
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Table 6. Differential Blood Count, Neutrophil Lymphocyte Ratio, and Platelet 
Lymphocyte Ratio Results among Covid-19 Patients with Another Disease 
 
Variable   n=5 
n % Mean SD Min Max 
Basophil (0-2%) 
  
0.28 0.13 0.1 0.4 
Normal 5 100.00 
    
Eosinophil (0-6%) 
  
0.84 1.06 0.1 2.7 
Normal 5 100.00 
    
Neutrophil (40-70%) 
  
80.16 6.43 72.5 89.2 
Normal 1 20.00 
    
High 4 80.00 
    
Lymphocyte (15-45%) 
  
12.8 3.79 7.8 16.8 
Normal 5 100.00 
    
Monocyte (0-10%) 
  
5.92 2.86 2.6 10 
Normal 4 80.00 
    
High 1 20.00 
    
Basophil (0-0.15 x106/L) 
  
0.04 0.05 0 0.1 
Normal 5 100.00 
    
Eosinophil (0-0.5 x 106/L) 
  
0.1 0.17 0 0.4 
Normal 5 100.00 
    
Neutrophil (1.26-7.3 x 
106/L) 
  
9.92 4.33 3.9 14.8 
Normal 1 20.00 
    
High 4 80.00 
    
Lymphocyte (0.8-4 x 
106/L) 
  
1.42 0.34 0.9 1.8 
Normal 5 100.00 
    
Monocyte (0.1-0.8 x 
106/L) 
  
0.62 0.19 0.4 0.9 
Normal 4 80.00 
    
High 1 20.00 
    
NLR (3.13-5) 
  
6.9 2.83 4.3 11.4 
High 2 40.00 
    
PLR (>180) 
  
198.5 116 94.5 380 
Normal 3 60.00 
    
High 2 40.00 
    
 
The limitation of this study is that the data still limit to 85 patients. A higher 
number of data can enhance the study. Another limitation is that CBCs cannot be used 
as a determining indicator of the presence of the Covid-19 virus in a patient's blood. 
This complete blood count is more precisely used as a supporting parameter in 
determining the patient's severity or recovery during the treatment period. Careful 
evaluation of whole blood parameters at the start and during the disease can help 
clinicians formulate a tailored treatment approach and promptly provide intensive care 
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CONCLUSION 
Most of the CBCs findings among Covid-19 patients at Covid-19 reference 
hospitals in West Nusa Tenggara show normal value among patients with no disease 
other than Covid-19. Older age and having comorbidities show a complete blood cell 
picture different from other Covid-19 patients who have confirmed positive without 
comorbidities. Several studies that have been conducted in several countries, 
especially those outsides of Wuhan, China, show some similarities in the percentage 
of blood cell levels from hematological parameters that tend to be normal. The next 
study should add a greater number of patient’s data so the result can be generalized. 
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